Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'Nichols_D' OR with Authors including 'Nichols_D' OR with Abstract including 'Nichols_D' OR with Keywords including 'Nichols_D'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Antun F, Smythies JR, Ben... Native Fluorescence and Hallucinogenic Potency of Some Amphetamines Experientia 1971
Barfknecht CF, Nichols DE Potential psychotomimetics, Bromomethoxyamphetamines J Med Chem 1971
Barfknecht CF, Nichols DE Potential psychotomimetics. Bromomethoxyamphetamines J Med Chem 1971
Barfknecht CF, Nichols DE Effects of S-+- and R---3,4,Dimethoxyphenylisopropylamines in the rat J Med Chem 1972
Barfknecht CF, Nichols DE Effects of S-(+)- and R-(-)-3,4,dimethoxyphenylisopropylamines in the ... J Med Chem 1972
Nichols DE, Barfknecht CF... Asymmetric synthesis of psychotomimetic phenylisopropylamines J Med Chem 1973
Barfknecht CF, Nichols DE... Potential Psychotomimetics. 2-Amino-1,2,3,4-tetrahydronaphthalene Anal... J Med Chem 1973
Nichols DE Potential Psychotomimetics Bromomethoxyamphetamines And Structural Con... Diss.Abstr.Intern. B 1973
Cheng HC, Long JP, Barfkn... Cardiovascular effects of 2, 5-dimethoxy-4-methylamphetamine DOM, STP J Pharmacol Exp Ther 1973
Dyer DC, Nichols DE, Rust... Comparative effects of stereoisomers of psychotomimetic phenylisopropy... Life Sci 1973
Cheng HC, Long JP, Nichol... Effects of psychotomimetics on vascular strips: studies of methoxylate... J Pharmacol Exp Ther 1974
Nichols DE, Barfknecht CF... Potential psychotomimetics. 2. Rigid analogs of 2,5-dimethoxy-4-methyl... J Med Chem 1974
Nichols DE, Ilhan M, Long... Comparison of Cardiovascular, Hyperthermic, and Toxic Effects of Para-... Arch Int de Pharmaco... 1975
Barfknecht CF, Nichols DE... Correlation of psychotomimetic activity of phenethylamines and ampheta... J Med Chem 1975
Nichols DE Structural Correlation between Apomorphine and LSD: Involvement of Dop... J. Theor. Biol. 1976
Anderson GM 3d, Braun G, ... Absolute configuration and psychotomimetic activity NIDA Res Monogr 1978
Shulgin AT, Nichols DE Characterization of three new psychotomimetics. The Pharmacology of Ha... The Psychopharmacolo... 1978
Nichols DE Phenethylamine Hallucinogens: New Structural Analogy and Implications ... Life Sci. 1978
Yim GKW, Nichols DE, Pfis... Stereoselective Actions of Hallucinogen Analogues Pharmacologist 1978
Braun U, Braun G, Jacob P... Mescaline analogs: substitutions at the 4-position NIDA Res Monogr 1978
Ferrigni NR, Nichols DE, ... Cactus alkaloidsXLVIIN alpha-dimethylhistamine, a hypotensive componen... J Ethnopharmacol 1982
Nichols DE, Lloyd DH, Hof... Effects of certain hallucinogenic amphetamine analogues on the release... J Med Chem 1982
Hoffman AJ, Nichols DE Synthesis and LSD-like discriminative stimulus properties in a series ... J Med Chem 1985
Johnson MP, Hoffman AJ, N... Effects of the enantiomers of MDA, MDMA and related analogues on [3H]s... Eur J Pharmacol 1986
Nichols DE Differences between the mechanism of action of MDMA, MBDB, and the cla... J Psychoactive Drugs 1986
Nichols DE, Hoffman AJ, O... Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives ... J Med Chem 1986
Ricaurte GA, Finnegan KF,... 3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, pr... Eur J Pharmacol 1987
Steele TD, Nichols DE, Yi... Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and... Biochem Pharmacol 1987
Oberlender R, Nichols DE Drug discrimination studies with MDMA and amphetamine Psychopharmacology (... 1988
Dimpfel W, Spuler M, Nich... Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting... Psychopharmacology (... 1989
Johnson MP, Nichols DE Neurotoxic effects of the alpha-ethyl homologue of MDMA following suba... Pharmacol Biochem Be... 1989
Nichols DE, Oberlender R Structure-activity relationships of MDMA-like substances NIDA Res Monogr 1989
Nichols DE, Oberlender R,... Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA... Pharmacol Biochem Be... 1989
Steele TD, Nichols DE, Yi... MDMA transiently alters biogenic amines and metabolites in mouse brain... Pharmacol Biochem Be... 1989
Johnson MP, Huang XM, Obe... Behavioral, biochemical and neurotoxicological actions of the alpha-et... Eur J Pharmacol 1990
Nichols DE, Brewster WK, ... Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amph... J Med Chem 1990
Nichols DE, Oberlender R Structure-activity relationships of MDMA and related compounds: a new ... Ann N Y Acad Sci 1990
Oberlender R, Nichols DE (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative... J Pharmacol Exp Ther 1990
Oberlender R, Nichols DE Structural variation and (+)-amphetamine-like discriminative stimulus ... Pharmacol Biochem Be... 1991
Johnson MP, Frescas SP, O... Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... J Med Chem 1991
Callaway CW, Johnson MP, ... Amphetamine derivatives induce locomotor hyperactivity by acting as in... Psychopharmacology (... 1991
Huang XM, Johnson MP, Nic... Reduction in brain serotonin markers by alpha-ethyltryptamine (Monase) Eur J Pharmacol 1991
Johnson MP, Conarty PF, N... [3H]monoamine releasing and uptake inhibition properties of 3,4-methyl... Eur J Pharmacol 1991
Johnson MP, Frescas SP, O... Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... J Med Chem 1991
Johnson MP, Huang XM, Nic... Serotonin neurotoxicity in rats after combined treatment with a dopami... Pharmacol Biochem Be... 1991
Nash JF, Nichols DE Microdialysis studies on 3,4-methylenedioxyamphetamine and structurall... Eur J Pharmacol 1991
Nichols DE, Johnson MP, O... 5-Iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamine Pharmacol Biochem Be... 1991
Steele TD, Brewster WK, J... Assessment of the role of alpha-methylepinine in the neurotoxicity of ... Pharmacol Biochem Be... 1991
Huang X, Marona-Lewicka D... p-Methylthioamphetamine is a Potent New Non-Neurotoxic Serotonin-Relea... Eur J Pharmacol 1992
Huang X, Marona-Lewicka D... p-methylthioamphetamine is a potent new non-neurotoxic serotonin-relea... Eur J Pharmacol 1992
Huang X, Nichols DE 5-HT2 receptor-mediated potentiation of dopamine synthesis and central... Eur J Pharmacol 1993
Monte AP, Marona-Lewicka ... Synthesis and pharmacological examination of benzofuran, indan, and te... J Med Chem 1993
Marona-Lewicka D, Nichols... Behavioral effects of the highly selective serotonin releasing agent 5... Eur J Pharmacol 1994
Nash JF, Roth BL, Brodkin... Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl in... Neurosci Lett 1994
Sprague JE, Huang X, Kant... Attenuation of 3,4-methylenedioxymethamphetamine (MDMA) induced neurot... Life Sci 1994
Pfaff RC, Huang X, Marona... Lysergamides Revisited NIDA Research Monogr... 1994
Nichols DE, Frescas S, Ma... 1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent s... J Med Chem 1994
Watts VJ, Lawler CP, Fox ... LSD and structural analogs: pharmacological evaluation at D1 dopamine ... Psychopharmacology (... 1995
Sprague JE, Nichols DE The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-meth... J Pharmacol Exp Ther 1995
Sprague JE, Nichols DE Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the... Psychopharmacology (... 1995
Marona-Lewicka D, Rhee GS... Psychostimulant-like effects of p-fluoroamphetamine in the rat Eur J Pharmacol 1995
Marona-Lewicka D, Rhee GS... Reinforcing effects of certain serotonin-releasing amphetamine derivat... Pharmacol Biochem Be... 1996
Sprague JE, Johnson MP, S... Studies on the mechanism of p-chloroamphetamine neurotoxicity Biochem Pharmacol 1996
Waldman SR, Monte AP, Bra... One-Pot Claisen Rearrangement / O-Methylation / Alkene Isomerization i... Tetrahedron Letters 1996
Monte AP, Marona-Lewicka ... Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substitut... J Med Chem 1996
Nichols DE, Monte A, Huan... Stereoselective pharmacological effects of lysergic acid amides posses... Behav Brain Res 1996
Monte AP, Waldman SR, Mar... Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives J Med Chem 1997
Lieberman JA, Mailman RB,... Serotonergic basis of antipsychotic drug effects in schizophrenia Biol Psychiatry 1998
Sprague JE, Everman SL, N... An integrated hypothesis for the serotonergic axonal loss induced by 3... Neurotoxicology 1998
Parker MA, Marona-Lewicka... Synthesis and pharmacological evaluation of ring-methylated derivative... J Med Chem 1998
Monte AP, Marona-Lewicka ... Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hy... J Med Chem 1998
Vangveravong S, Kanthasam... Synthesis and serotonin receptor affinities of a series of trans-2-(in... J Med Chem 1998
Parker MA, Marona-Lewicka... A novel (benzodifuranyl)aminoalkane with extremely potent activity at ... J Med Chem 1998
Blair JB, Marona-Lewicka ... Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the ... J Med Chem 1999
Blair JB, Kurrasch-Orbaug... Effect of ring fluorination on the pharmacology of hallucinogenic tryp... J Med Chem 2000
Chambers JJ, Kurrasch-Orb... Enantiospecific synthesis and pharmacological evaluation of a series o... J Med Chem 2001
Laban U, Kurrasch-Orbaugh... A novel fluorinated tryptamine with highly potent serotonin 5-HT1A rec... Bioorg Med Chem Lett 2001
Nichols DE LSD and Its Lysergamide Cousins Heffter Review 2001
Falk EM, Cook VJ, Nichols... An antisense oligonucleotide targeted at MAO-B attenuates rat striatal... Pharmacol Biochem Be... 2002
Chambers JJ, Kurrasch-Orb... Translocation of the 5-alkoxy substituent of 2,5-dialkoxyarylalkylamin... Bioorg Med Chem Lett 2002
Nichols DE, Frescas S, Ma... Lysergamides of isomeric 2,4-dimethylazetidines map the binding orient... J Med Chem 2002
Kanthasamy A, Sprague J, ... Unilateral infusion of a dopamine transporter antisense into the subst... Neuroscience 2002
Chambers JJ, Parrish JC, ... Synthesis and pharmacological characterization of a series of geometri... J Med Chem 2003
Nichols DE Hallucinogens Pharmacology & Thera... 2004
Sprague JE, Nichols DE Neurotoxicity of MDMA (ecstasy): beyond metabolism Trends in Pharmacolo... 2005
Gallardo-Godoy A, Fierro ... Sulfur-substituted alpha-alkyl phenethylamines as selective and revers... J Med Chem 2005
Marona-Lewicka D, Thisted... Distinct temporal phases in the behavioral pharmacology of LSD: dopami... Psychopharmacology (... 2005
Parrish JC, Braden MR, Gu... Differential phospholipase C activation by phenylalkylamine serotonin ... J Neurochem 2005
Nichols DE Commentary on: Psilocybin can occasion mystical-type experiences havin... Psychopharmacology (... 2006
Callaway JC, Grob CS, McK... A demand for clarity regarding a case report on the ingestion of 5-met... J Anal Toxicol 2006
McLean TH, Parrish JC, Br... 1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinog... J Med Chem 2006
Parrish JC, Nichols DE Serotonin 5-HT(2A) receptor activation induces 2-arachidonoylglycerol ... J Neurochem 2006
Braden MR, Parrish JC, Na... Molecular interaction of serotonin 5-HT2A receptor residues Phe339(651... Mol Pharmacol 2006
Selken J, Nichols DE Alpha1-adrenergic receptors mediate the locomotor response to systemic... Pharmacol Biochem Be... 2007
Marona-Lewicka D, Nichols... Further evidence that the delayed temporal dopaminergic effects of LSD... Pharmacol Biochem Be... 2007
Nichols DE, Nichols CD Serotonin Receptors Chem Rev 2008
Nichols DE, Frescas SP, C... High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimetho... Bioorg Med Chem 2008
Marona-Lewicka D, Chemel ... Dopamine D(4) receptor involvement in the discriminative stimulus effe... Psychopharmacology (... 2008
Marona-Lewicka D, Chemel ... Dopamine D(4) receptor involvement in the discriminative stimulus effe... Psychopharmacology (... 2009
Nichols D Legal highs: the dark side of medicinal chemistry Nature 2011

Page 1 of 2   /   110 Entries Returned
Pages:     
 1 
2 next